• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Ascensia Diabetes Care

Senseonics wins FDA nod for 365-day implantable CGM

September 17, 2024 By Sean Whooley

Senseonics (NYSE:SENS) is set to bring the longest-lasting continuous glucose monitor (CGM) to market following a major regulatory nod. Our sister site, Drug Delivery Business News, reports today that Senseonics received FDA clearance for its next-generation Eversense 365 CGM system. With the clearance, Eversense 365 becomes the world’s first 365-day CGM system, helping people with […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Implants, Patient Monitoring, Regulatory/Compliance Tagged With: Ascensia Diabetes Care, FDA, Senseonics

The steps ahead for the Eversense implantable CGM platform

June 24, 2024 By Sean Whooley

As Senseonics and Ascensia Diabetes Care looked for someone to help scale their CGM business, they turned to someone had only just retired. After close to eight years as Tandem Diabetes Care CCO, Brian Hansen notified the company of his decision to step down last August. His final day landed on Dec. 31, but he […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Health Technology, Implants, Patient Monitoring Tagged With: Ascensia Diabetes Care, Senseonics

Ascensia, Senseonics announce new CGM cost savings

March 12, 2024 By Sean Whooley

Ascensia Diabetes Care and Senseonics today announced an extension to their Eversense Payment Assistance and Simple Savings (PASS) program. The program aims to help people in the U.S. access the Eversense E3 continuous glucose monitor (CGM) more affordably. It offers major savings for eligible individuals looking to experience the benefits of the long-term, implantable CGM. […]

Filed Under: Business/Financial News, Diabetes, Health Technology, Implants, Patient Monitoring Tagged With: Ascensia Diabetes Care, Senseonics

Former Tandem CCO joins Ascensia as president of CGM

February 6, 2024 By Sean Whooley

Ascensia Diabetes Care parent company PHC Holdings and Senseonics announced today that Ascensia named Brian Hansen its president of CGM. Hansen’s appointment to the newly created role at the global distributor of Senseonics’ Eversense CGM went into effect today, Feb. 6. Responsibilities for Hansen include the global commercialization and growth of the Eversense system. The fully […]

Filed Under: Business/Financial News, Diabetes, Implants, Patient Monitoring Tagged With: Ascensia Diabetes Care, Personnel Moves, Senseonics

Here’s what diabetes tech companies are doing on World Diabetes Day

November 14, 2023 By Sean Whooley

Every November, the diabetes community comes together to recognize both National Diabetes Month in the U.S. and World Diabetes Day. World Diabetes Day falls on today, Nov. 14, to mark the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles Herbert Best in 1922. In an effort to drive awareness and […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, In-Depth Coverage, Patient Monitoring, Special Content Tagged With: Abbott, Ascensia Diabetes Care, Dexcom, Insulet, Medtronic, Senseonics

Ascensia Diabetes Care inks deal to integrate blood glucose monitors in point-of-care testing

July 19, 2023 By Sean Whooley

Avricore Health and Ascensia Diabetes Care announced a partnership to integrate blood glucose monitoring into point-of-care testing. The deal aims to integrate the Contour Next-Gen and Contour Next One BGM systems into Avricore’s HealthTab PCOT platform. Both companies have the objective of supporting patients and pharmacists in Canada to better manage diabetes. The companies believe […]

Filed Under: Business/Financial News, Diabetes, Diagnostics, Digital Health, Featured, Health Technology, News Well, Patient Monitoring, Software / IT Tagged With: Ascensia Diabetes Care, Avricore Health

Ascensia expands payment program for Senseonics Eversense E3 CGM

May 9, 2023 By Sean Whooley

Ascensia Diabetes Care announced today that it expanded the Eversense PASS program for the Senseonics (NYSE:SENS) Eversense E3 CGM. Eversense PASS, a payment assistance and simple savings program, aims to enhance affordability and access to Eversense E3. Ascensia serves as the global commercial partner for Senseonics. The Senseonics continuous glucose monitor (CGM), a 180-day implantable […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Implants, Patient Monitoring Tagged With: Ascensia Diabetes Care, Senseonics

Ascensia partners with Snaq on diabetes management

February 21, 2023 By Sean Whooley

Ascensia Diabetes Care announced today that it entered into a global collaboration with diabetes management company Snaq. Snaq develops an app-based solution offering insights on food and nutrition for people with diabetes. Ascensia develops the Controu blood glucose monitoring system and distributes Senseonics’ Eversense CGM systems. The companies plan to integrate technologies to help with […]

Filed Under: Business/Financial News, Diabetes, Health Technology, Patient Monitoring, Software / IT Tagged With: Ascensia Diabetes Care, Snaq

Ascensia Diabetes integrates its Eversense CGM with Apple Health

November 7, 2022 By Danielle Kirsh

Ascensia Diabetes Care announced today that it has updated its Eversense Continuous Glucose Monitoring system app to integrate with Apple Health. The Parsippany, N.J.-based company makes the Contour Blood Glucose Monitoring (BGM) system and distributes Senseonics’ Eversense CGM system. The new Apple Health integration will allow people with diabetes using Senseonics’ Eversense CGM systems to […]

Filed Under: Business/Financial News, Diabetes, Digital Health, Featured, News Well Tagged With: Ascensia Diabetes Care, continuous glucose monitor, Senseonics

Ascensia, Senseonics partner with Nurse Practitioner Group on CGM insertion options

November 3, 2022 By Sean Whooley

Senseonics (NYSE:SENS) and Ascensia Diabetes Care launched a collaboration with the Nurse Practitioner Group (NPG) today. NPG offers multidisciplinary health services and medical staffing solutions. The collaboration aims to broaden access to the Eversense E3 continuous glucose monitor (CGM) system. Senseonics developed Eversense E3 and Ascensia distributes the system as the company’s partner. The collaboration […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Health Technology, Patient Monitoring Tagged With: Ascensia Diabetes Care, Senseonics

Ascensia launches online diabetes management, analytics platform in U.S.

November 2, 2022 By Sean Whooley

Ascensia Diabetes Care announced today that it launched its online diabetes management and analytics platform in the U.S. Parsippany, New Jersey-based Ascensia now offers GlucoContro.online in more than 15 countries around the world. It plans for further expansion, too. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Big Data, Business/Financial News, Diabetes, Digital Health, Drug-Device Combinations, Electronic Medical Records (EMR), Health Technology, Patient Monitoring, Software / IT Tagged With: Ascensia Diabetes Care

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy